Identification of ADGRE5 as Discriminating MYC Target Between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5537-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Distinction Between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma With C-Myc Rearrangement

Modern Pathology
Forensic MedicinePathology
2002English

A B-Cell Lymphoma Case That Is Unclassifiable, and Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma of Lacrimal Gland

International Medical Case Reports Journal
Medicine
2017English

Diffuse Large B-Cell Lymphoma

2020English

Vitreoretinal Lymphoma Followed by Systemic Diffuse Large B Cell Lymphoma

Journal of Ophthalmic Inflammation and Infection
OphthalmologyInfectious Diseases
2019English

ALK -Positive Diffuse Large B-Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Diffuse Large B-Cell Lymphoma Presenting as a Cardiac Mass

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2016English

Distinction Between "High Grade MALT" and Diffuse Large B Cell Lymphoma

Gut
Gastroenterology
2002English

Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma

Seminars in Diagnostic Pathology
Forensic MedicinePathology
2011English

The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy